Key Points
- CEO Sean Keohane sold 2,779 Cabot shares at an average price of $85.50, generating $237,604.50. After the transaction, he retained 288,873 shares valued at approximately $24.7 million.
- Cabot’s latest quarterly results slightly exceeded expectations, with earnings of $1.67 per share and revenue of $982 million, up 6.4% year over year. The company guided to fiscal 2026 earnings of $6.15–$6.45 per share.
- The company declared a quarterly dividend of $0.4725 per share, equivalent to an annualized $1.89 and a 2.2% yield. Analysts maintain an average “Hold” rating with an average price target of $89.
Cabot Corporation (NYSE:CBT - Get Free Report) CEO Sean Keohane sold 2,779 shares of the company's stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $85.50, for a total value of $237,604.50. Following the sale, the chief executive officer owned 288,873 shares in the company, valued at approximately $24,698,641.50. This trade represents a 0.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Cabot Stock Performance
Shares of CBT opened at $84.68 on Thursday. The stock has a 50-day simple moving average of $87.91 and a 200-day simple moving average of $81.11. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The stock has a market capitalization of $4.37 billion, a PE ratio of 23.85, a PEG ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53.
Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, analysts predict that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.
Cabot Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. Cabot's dividend payout ratio is currently 53.24%.
Institutional Investors Weigh In On Cabot
Institutional investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio lifted its position in shares of Cabot by 15.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company's stock worth $80,000 after purchasing an additional 160 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in Cabot by 2.6% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company's stock worth $417,000 after buying an additional 161 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Cabot by 9.6% during the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company's stock worth $124,000 after buying an additional 164 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of Cabot by 10.5% in the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company's stock valued at $139,000 after acquiring an additional 175 shares in the last quarter. Finally, Swiss Life Asset Management Ltd increased its position in shares of Cabot by 3.6% in the second quarter. Swiss Life Asset Management Ltd now owns 6,147 shares of the specialty chemicals company's stock valued at $558,000 after acquiring an additional 212 shares during the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the stock. Truist Financial set a $100.00 price target on shares of Cabot in a report on Wednesday, August 5th. UBS Group reduced their price objective on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research note on Wednesday, August 5th. Mizuho boosted their price target on Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a research note on Thursday, June 25th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cabot in a research note on Friday, August 21st. Finally, Wall Street Zen raised Cabot from a "hold" rating to a "buy" rating in a report on Sunday, August 9th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $89.00.
View Our Latest Stock Report on Cabot
About Cabot
(
Get Free Report)
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
